Warning: Covid Vaccines! Huge Risks, Huge Injuries – Huge Compensations?

[Braveheart]

Warning: Covid Vaccines! Huge Risks, Huge Injuries – Huge Compensations? - Global Research

Did you know that the US Government since 1988 paid as of 1 December 2020 more than 4.4 billion dollars to vaccine-injury victims? – It’s your money – Taxpayers Money. This is Health Services and Service Administration Vaccine Injury Compensation Data The National Vaccine Injury Compensation...

www.globalresearch.ca

Gates role in this makes me extremely angry.

 

[Peatness]

Warning: Covid Vaccines! Huge Risks, Huge Injuries – Huge Compensations? - Global Research

Did you know that the US Government since 1988 paid as of 1 December 2020 more than 4.4 billion dollars to vaccine-injury victims? – It’s your money – Taxpayers Money. This is Health Services and Service Administration Vaccine Injury Compensation Data The National Vaccine Injury Compensation...

www.globalresearch.ca

Gates role in this makes me extremely angry.

8 Months later and still no stopping them

Dr Sherri Tenpenny and Dr Andrew Wakefield Discuss The "Clot shot"​

View: https://www.bitchute.com/video/6Hd8j8nStDXL/

 

[Grapelander]

You have to go against the DOJ - most do not succeed. The ones that do are probably lawyers.

Under PREP Act no one appears to be liable unless they do something crazy like give you 10 doses at a time.

FDA: the PREP Act authorizes the HHS Secretary to issue a declaration (called a PREP Act declaration) that provides immunity (except for willful misconduct) for claims related to administration or use of countermeasures against CBRN agents to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of such countermeasures.82 The PREP Act authority, including the authority to issue PREP Act declarations, resides with the Secretary of HHS and has not been delegated to FDA.

The PREP Act liability protections apply to “covered countermeasures” as defined by the statute.83 Covered countermeasures include medical products that are approved, cleared, or licensed by FDA; authorized for investigational use under an IND or IDE by FDA; authorized for emergency use under section 564; or otherwise permitted to be held or used pursuant to sections 564A and 564B. As discussed in section IV of this guidance, in the past, EUAs have been issued in part to address concerns that certain activities related to MCMs potentially violated provisions of the FD&C Act, jeopardizing otherwise-applicable PREP Act protections. PAHPRA added sections 564A and 564B to the definitions of “covered countermeasure” in part to preserve these otherwise-applicable PREP Act protections.